Evaluation of the Early Conversion From a Calcineurin Inhibitor-based Immunosuppressive Regimen to Everolimus in de Novo Renal Transplant Recipients, a Multicenter Experience
Phase of Trial: Phase IV
Latest Information Update: 11 Jun 2013
At a glance
- Drugs Ciclosporin; Everolimus; Mycophenolate sodium; Steroids; Tacrolimus
- Indications Transplant rejection
- Focus Adverse reactions
- 01 May 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 14 Mar 2013 Planned End Date changed from 1 Dec 2014 to 1 Dec 2015 as reported by ClinicalTrials.gov.
- 14 Mar 2013 Planned initiation date changed from 1 Jun 2012 to 1 Mar 2013 as reported by ClinicalTrials.gov.